Katia Bassett

Katia Bassett has extensive experience in the field of diagnostics and translational medicine, highlighted by leadership roles at Genentech from November 2015 to June 2021, including Senior Director and Head of CDx Development, where strategic oversight was provided for diagnostic assays across a wide range of indications. Key achievements include overseeing two major companion diagnostics approvals and fostering cross-organizational alignment. Prior roles at Geron Corporation involved leading translational biomarker efforts and managing academic collaborations, while early career research at Lawrence Berkeley National Laboratory focused on cancer cell biology. Katia Bassett holds a Ph.D. in Biochemistry from the University of North Carolina at Chapel Hill.